Kiorpes 2021 J Biol Chem: Difference between revisions
No edit summary |
No edit summary ย |
||
Line 1: | Line 1: | ||
{{Publication | {{Publication | ||
|title=Kiorpes TC, Hoerr D, Ho W, Weaner LE, Inman MG, Tutwiler GF (2021) Identification of 2-tetradecylglycidyl coenzyme A as the active form of methyl 2-tetradecylglycidate (methyl palmoxirate) and its characterization as an irreversible, active site-directed inhibitor of carnitine palmitoyltransferase A in isolated rat liver mitochondria. J Biol Chem 259:9750-5 | |title=Kiorpes TC, Hoerr D, Ho W, Weaner LE, Inman MG, Tutwiler GF (2021) Identification of 2-tetradecylglycidyl coenzyme A as the active form of methyl 2-tetradecylglycidate (methyl palmoxirate) and its characterization as an irreversible, active site-directed inhibitor of carnitine palmitoyltransferase A in isolated rat liver mitochondria. J Biol Chem 259:9750-5. | ||
|info=[https://pubmed.ncbi.nlm.nih.gov/6547720/ PMID:6547720] | |info=[https://pubmed.ncbi.nlm.nih.gov/6547720/ PMID:6547720] | ||
|authors=Kiorpes TC, Hoerr D, Ho W, Weaner LE, Inman MG, Tutwiler GF | |authors=Kiorpes TC, Hoerr D, Ho W, Weaner LE, Inman MG, Tutwiler GF |
Latest revision as of 22:54, 5 July 2021
Kiorpes TC, Hoerr D, Ho W, Weaner LE, Inman MG, Tutwiler GF (2021) Identification of 2-tetradecylglycidyl coenzyme A as the active form of methyl 2-tetradecylglycidate (methyl palmoxirate) and its characterization as an irreversible, active site-directed inhibitor of carnitine palmitoyltransferase A in isolated rat liver mitochondria. J Biol Chem 259:9750-5. |
ยป PMID:6547720
Kiorpes TC, Hoerr D, Ho W, Weaner LE, Inman MG, Tutwiler GF (2021) J Biol Chem
Abstract: Methyl-2-tetradecylglycidic acid (MeTDGA) has been hypothesized to inhibit fatty acid oxidation by irreversible, active site-directed inactivation of carnitine palmitoyltransferase A after being converted to TDGA-CoA. Using synthetic TDGA-CoA, this hypothesis has been confirmed. Assessing enzyme inhibition in an isolated rat liver mitochondrial system, TDGA-CoA (synthetic or enzyme prepared) was more potent than TDGA or MeTDGA and retained activity in the absence of CoA or Mg2+-ATP. It inhibited palmitoyl-CoA but not palmitoyl carnitine oxidation. Enzyme inactivation was exponential, stereospecific, and fast (t0.5 = 38.5 s with 100 nM (R)-TDGA-CoA). TDGA-CoA was identified as a complexing type irreversible inhibitor (Ki approximately 0.27 microM) by the double reciprocal relationship between the pseudo-first order inactivation rate and its concentration, by the inverse dependence of the second order rate constant on its concentration, and by the independence of the first order rate from the enzyme concentration. Palmitoyl-CoA, CoA, and malonyl-CoA protected the enzyme, while L-carnitine and palmitoyl-L-carnitine were without effect. [3-14C] TDGA-CoA labeled a protein, Mr = 90,000, with a time course which paralleled that of enzyme inhibition; maximum specific binding was 16 pmol/mg of mitochondrial protein.
Cited by
- Silva et al (2021) Off-target effect of etomoxir on mitochondrial Complex I. MitoFit Preprints 2021. (in preparation)
Labels:
MitoFit 2021 Etomoxir